Investors representing $13 trillion in assets are urging global leaders to intensify their initiatives aimed at curbing the use of antibiotics within the meat industry and other sectors.
In a collective move, approximately 80 investment groups endorsed a statement from the Investor Action on Antimicrobial Resistance (IAAMR). This announcement coincided with the UN General Assembly’s ongoing discussions on antimicrobial resistance this month.
Among these investment entities is the UK-based FAIRR Initiative, which has raised serious concerns regarding the reliance on antibiotics within the meat sector. They warn that such practices contribute to the emergence of antimicrobial resistance (AMR) in humans, posing a significant threat to public health and environmental stability.
IAAMR has likened this challenge to a systemic risk on par with challenges like the Covid-19 pandemic and the 2008 financial crisis. It highlighted that, in 2019, AMR caused more fatalities than HIV/AIDS and malaria combined. Furthermore, the economic ramifications of AMR could lead to annual treatment and productivity losses projected to reach $412 billion and $443 billion respectively by 2035.
Jeremy Coller, founder of FAIRR, emphasized, “An estimated 80% of antibiotics are administered to livestock rather than people in the US alone. Investors recognize that AMR is not only a threat to the health of our people and planet but to the financial well-being of those who rely on investment returns to fund their retirements.”
The 80 signatory investors, which include prominent names like Legal & General Investment Management (LGIM) and HESTA, have put forth seven crucial requests for global leaders and policymakers. Their calls encompass the establishment of science-based guidelines, effective antibiotic stewardship, and a comprehensive ‘One Health’ strategy that integrates animal, human, and environmental health.
FAIRR’s analysis indicates that since 2020, there have been at least 20 shareholder resolutions focusing on AMR risks across various global supply chains, ranging from pharmaceutical manufacturers to food retailers and restaurant operators.
Earlier this year, the UK government committed £85 million ($111.5 million) to support the development of new antibiotics, enhance global health infrastructure, and strengthen monitoring systems for AMR threats.
In regard to the IAAMR statement, Just Food has reached out to industry organizations, including the British Meat Processors Association and the British Pig Association, for their feedback.
In this rapidly evolving landscape, stakeholders in the food and beverage industry must stay informed of the latest trends and challenges surrounding antibiotic use in livestock. The implications extend beyond health and safety to encompass broader food and drink consumer trends, further emphasizing the necessity for proactive measures in the food and drink business.
In conclusion, the dialogue surrounding antibiotics in meat production is critical. As the industry adapts to evolving consumer demands and regulatory standards, understanding these dynamics will prove advantageous for all parties involved.
